Category: Medical
-

STAT+: European firms raise two big funds for early biotech
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about Novo plans for Wegovy, a Purdue bankruptcy deal, and more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-

STAT+: China’s WuXi AppTec, after evading threat of U.S. restrictions, comes out ahead
•
For nearly two years, WuXi AppTec, the Chinese contract research giant with extensive ties with U.S. biotech and…
-

Opinion: STAT+: Sanofi CEO: How we’re measuring AI success
•
With tech powerhouses forming billion dollar alliances — from NVIDIA and OpenAI to AMD and IBM’s partnership with…
-

STAT+: Pfizer closes $10 billion Metsera deal
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
•
NEW YORK — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest…
-

STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-

STAT+: Pharmalittle: We’re reading about a Merck acquisition, Novo facing shareholder backlash, and more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-

STAT+: Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial
•
A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson & Johnson failed in…
-

STAT+: Merck to buy Cidara, maker of a flu prevention drug, for $9.2B
•
Merck said Friday it would buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2…
-

Opinion: The era of safe bets in psychiatric medicine is over
•
For decades, the pharmaceutical industry’s approach to mental health was a playbook of conservative, incremental innovation. The market…
-

STAT+: Makary, Prasad outline pathway for bespoke gene therapy
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pfizer signals brewing digital health work
•
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the…
-

STAT+: Pharmalittle: We’re reading about Trump and patent policies, a new malaria drug, and more
•
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
-

STAT+: New patent office polices may make it harder for lower-cost medicines to reach consumers
•
File this under “unintended consequences.” Over the past few months, the U.S. Patent and Trademark Office has pursued…
-

STAT+: AbbVie cuts ties with Google-backed longevity company, lays off scientists
•
AbbVie is ending a decade-long partnership with Calico Life Sciences, an Alphabet-funded biotech company focused on aging research,…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement




